Capex Boom, Like Everything Else, Is A Mag7 Story

First thing this week, in "The Numbers Behind America's AI Dominance," I cited capex and R&D figures which underscore the extent to which the mega-cap names we all know and love (in some cases to hate) have come to monopolize (figuratively and literally) the AI arms race. You can read the linked article for yourself (it's short), but the gist of it is just that the Magnificent 7 are (is) blowing through hundreds of billions of dollars in a bid to stay at the forefront of what Jensen Huang s

You need a PLUS account to view this content. Try one month of PLUS for FREE.

Try PLUS for free

Already have an account? log in

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

5 thoughts on “Capex Boom, Like Everything Else, Is A Mag7 Story

    1. The cash flow comes first. That is the supply. The uses include buybacks, R&D, Capex and the cost of growth. The faster a firm, especially a large one grows, the more capital is required to support that growth. If a firm is doubling in size it will need to double its working capital, plant capacity, labor, support and other expenses. If the growth in some of that support can grow at a slightly lower rate as a result of short-term productivity increases, that will help, but high rates of growth, say 30% or more, lots of cash will be required. Increasing competition, market forces, input prices and other factors can compress operating margins and lower free cash flow. IMO, buybacks are the least defensible uses of free cash.

  1. I never bought in to the storyline about buying the Russell 2000 because, collectively, it was supposed to “catch up” in performance with SP500. However, I am looking at a few smaller companies that don’t have a debt problem, have increasing cash flow, and have cap ex budgets for solid and sustainable business opportunities (not solely for AI).

NEWSROOM crewneck & prints